Cited by 1,196Epigenetics and DNA MethylationCancer-related gene regulationGenomics and Chromatin Dynamics

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Open access

Bracken, Adrian P., Pasini, Diego, Capra, Maria, Prosperini, Elena, Colli, Elena, Helin, Kristian·2003·The EMBO Journal

Open this paper in CoChat — free account

Abstract

Recent experiments have demonstrated that the Polycomb group (PcG) gene EZH2 is highly expressed in metastatic prostate cancer and in lymphomas. EZH2 is a component of the PRC2 histone methyltransferase complex, which also contains EED and SUZ12 and is required for the silencing of HOX gene expression during embryonic development. Here we demonstrate that both EZH2 and EED are essential for the proliferation of both transformed and non-transformed human cells. In addition, the pRB-E2F pathway tightly regulates their expression and, consistent with this, we find that EZH2 is highly expressed in a large set of human tumors. These results raise the question whether EZH2 is a marker of proliferation or if it is actually contributing to tumor formation. Significantly, we propose that EZH2 is a bona fide oncogene, since we find that ectopic expression of EZH2 is capable of providing a proliferative advantage to primary cells and, in addition, its gene locus is specifically amplified in several primary tumors.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/emboj/cdg542

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The hallmarks of cancer
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Tissue microarrays for high-throughput molecular profiling of tumor specimens
Kononen, J., Bubendorf, L., Kallionimeni, A., Barlund, M. T., Schraml, P., Leighton, S. B., Torhorst, J. K. H., Mihatsch, M. J., Sauter, G., & Kallionimeni, O.-P. (1998) · Nature Medicine · doi:10.1038/nm0798-844 · Cited by 4,101
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
The regulation of E2F by pRB-family proteins.
Dyson, N. (1998) · Genes & Development · doi:10.1101/gad.12.15.2245 · Cited by 2,317
Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein
Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.1035902 · Cited by 1,596
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580
Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex
Müller, J., Hart, C. M., Francis, N. J., Vargas, M. L., Sengupta, A. K., Wild, B., Miller, E., O’Connor, M. B., Kingston, R. E., & Simon, J. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00976-5 · Cited by 1,553
Drosophila Enhancer of Zeste/ESC Complexes Have a Histone H3 Methyltransferase Activity that Marks Chromosomal Polycomb Sites
Czermin, B., Melfi, R., McCabe, D., Seitz, V., Imhof, A., & Pirrotta, V. (2002) · Cell · doi:10.1016/s0092-8674(02)00975-3 · Cited by 1,536
Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors
Pollack, J. R., Sørlie, T., Perou, C. M., Rees, C. A., Jeffrey, S. S., Lønning, P. E., Tibshirani, R. J., Botstein, D., Børresen‐Dale, A., & Brown, P. O. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162471999 · Cited by 1,167

Show all 43 references

Sorted by citations

Items 501–600 of 999

Genomic Approaches That Aid in the Identification of Transcription Factor Target Genes
Kirmizis, A., & Farnham, P. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900803 · Cited by 54
Regulation of epigenetic homeostasis in uveal melanoma and retinoblastoma
Chai, P., Jia, R., Li, Y., Zhou, C., Gu, X., Yang, L., Shi, H., Tian, H., Lin, H., Yu, J., et al. (2021) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2021.101030 · Cited by 56
Expression Parameters of the Polycomb Group Proteins BMI1, SUZ12, RING1 and CBX7 in Urothelial Carcinoma of the Bladder and Their Prognostic Relevance
Hinz, S., Kempkensteffen, C., Christoph, F., Krause, H., Schrader, M., Schostak, M., Miller, K., & Weikert, S. (2008) · Tumor Biology · doi:10.1159/000170879 · Cited by 52
Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies
Sashida, G., & Iwama, A. (2016) · International Journal of Hematology · doi:10.1007/s12185-016-2124-x · Cited by 55
Praja1 E3 ubiquitin ligase promotes skeletal myogenesis through degradation of EZH2 upon p38α activation
Consalvi, S., Brancaccio, A., Dall’Agnese, A., Puri, P., & Palacios, D. (2017) · Nature Communications · doi:10.1038/ncomms13956 · Cited by 52
MUC1-C activates EZH2 expression and function in human cancer cells
Rajabi, H. N., Hiraki, M., Tagde, A., Alam, M., Bouillez, A., Christensen, C. L., Samur, M., Wong, K., & Kufe, D. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-07850-0 · Cited by 50
Proteomic analysis of EZH2 downstream target proteins in hepatocellular carcinoma
Chen, Y., Lin, M. C. M., Wang, H., Chan, C., Jiang, L., Ngai, S. M., Yu, J. Q., He, M., Shaw, P., Yew, D. T. W., et al. (2007) · PROTEOMICS · doi:10.1002/pmic.200700019 · Cited by 51
Expression Profile of the Polycomb Group Protein Enhancer of Zeste Homologue 2 and its Prognostic Relevance in Renal Cell Carcinoma
Hinz, S., Weikert, S., Magheli, A., Hoffmann, M. J., Engers, R., Miller, K., & Kempkensteffen, C. (2009) · The Journal of Urology · doi:10.1016/j.juro.2009.08.014 · Cited by 53
The histone methyltransferase EZH2, an oncogene common to benign and malignant parathyroid tumors
Svedlund, J., Barazeghi, E., Stalberg, P. L. H., Hellman, P., Åkerström, G., Björklund, P., & Westin, G. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0497 · Cited by 51
Enhancer of Zeste Homolog 2 and Histone Deacetylase 9c Regulate Age-Dependent Mesenchymal Stem Cell Differentiation into Osteoblasts and Adipocytes
Chen, Y.-H., Chung, C.-C., Liu, Y.-C., Yeh, S., Hsu, J. L., Hung, M., Su, H.-L., & Li, L. (2016) · Stem Cells · doi:10.1002/stem.2400 · Cited by 51
A687V EZH2 Is a Driver of Histone H3 Lysine 27 (H3K27) Hypertrimethylation
Ott, H. M., Graves, A. P., Pappalardi, M. B., Huddleston, M. J., Halsey, W. S., Hughes, A. M., Groy, A., Dul, E., Jiang, Y., Bai, Y., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0876 · Cited by 51
Targeting CSC-Related miRNAs for Cancer Therapy by Natural Agents
Bao, B., Li, Y., Ahmad, A., Azmi, A. S., Bao, G. W., Ali, S. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2012) · Current Drug Targets · doi:10.2174/138945012804545515 · Cited by 50
Role of EZH2 histone methyltrasferase in melanoma progression and metastasis
Mahmoud, F. A., Shields, B. D., Makhoul, I., Hutchins, L. F., Shalin, S. C., & Tackett, A. J. (2016) · Cancer Biology & Therapy · doi:10.1080/15384047.2016.1167291 · Cited by 53
Epigenetic deregulation in chronic lymphocytic leukemia: Clinical and biological impact
Mansouri, L., Wierzbińska, J. A., Plass, C., & Rosenquist, R. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.02.001 · Cited by 53
Drugging histone methyltransferases in cancer
Richart, L., & Margueron, R. (2020) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.11.009 · Cited by 51
Arabidopsis histone deacetylase 6: a green link to RNA silencing
Aufsatz, W., Stoiber, T., Rakic, B., & Naumann, K. (2007) · Oncogene · doi:10.1038/sj.onc.1210615 · Cited by 49
Identification of novel mammalian growth regulatory factors by genome-scale quantitative image analysisPreprint
Harada, J. N., Bower, K. E., Orth, A. P., Callaway, S., Nelson, C. G., Laris, C. A., Hogenesch, J. B., Vogt, P. K., & Chanda, S. K. (2005) · Genome Research · doi:10.1101/gr.3889305 · Cited by 50
Post-Translational Modifications of PCNA in Control of DNA Synthesis and DNA Damage Tolerance-the Implications in Carcinogenesis
Zhang, S., Zhou, T., Wang, Z., Yi, F., Li, C., Guo, W., Xu, H., Cui, H., Dong, X. D., Liu, J., et al. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.64628 · Cited by 51
Polyploid giant cancer cells, EZH2 and Myc upregulation in mammary epithelial cells infected with high-risk human cytomegalovirus
Nehme, Z., Pasquereau, S., Ahmad, S. H., Baba, R. E., & Herbein, G. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104056 · Cited by 48
PTEN controls β‐cell regeneration in aged mice by regulating cell cycle inhibitor p16 ink4a
Zeng, N., Yang, K., Bayan, J., He, L., Aggarwal, R., Stiles, J. W., Hou, X., Medina, V., Abad, D., Palian, B. M., et al. (2013) · Aging Cell · doi:10.1111/acel.12132 · Cited by 50
Developmental and androgenic regulation of chromatin regulators EZH2 and ANCCA/ATAD2 in the prostate Via MLL histone methylase complex
Duan, Z., Zou, J. X., Yang, P. X., Wang, Y. Z., Borowsky, A. D., Gao, A. C., & Chen, H. (2012) · The Prostate · doi:10.1002/pros.22587 · Cited by 49
Inhibition of EZH2 by chemo- and radiotherapy agents and small molecule inhibitors induces cell death in castration-resistant prostate cancer
Wu, C., Jin, X., Yang, H. J., Yang, Y., He, Y., Ding, L., Pan, Y., Chen, S., Jiang, J., & Huang, H. (2015) · Oncotarget · doi:10.18632/oncotarget.6497 · Cited by 49
Polycomb Protein OsFIE2 Affects Plant Height and Grain Yield in Rice
Liu, X., Wei, X., Sheng, Z., Jiao, G., Tang, S., Luo, J., & Hu, P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164748 · Cited by 51
EZH2 inhibitors: a patent review (2014-2016)
Stazi, G., Zwergel, C., Mai, A., & Valente, S. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1316976 · Cited by 49
The Long Non-Coding RNA Prader Willi/Angelman Region RNA5 (PAR5) Is Downregulated in Anaplastic Thyroid Carcinomas Where It Acts as a Tumor Suppressor by Reducing EZH2 Activity
Pellecchia, S., Sepe, R., Decaussin‐Petrucci, M., Ivan, C., Shimizu, M., Coppola, C., Testa, D., Calin, G. A., Fusco, A., & Pallante, P. (2020) · Cancers · doi:10.3390/cancers12010235 · Cited by 48
Dual targeting of the epigenome via FACT complex and histone deacetylase is a potent treatment strategy for DIPG
Ehteda, A., Simon, S., Franshaw, L., Giorgi, F. M., Liu, J., Joshi, S. M., Rouaen, J. R. C., Pang, C. N. I., Pandher, R., Mayoh, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108994 · Cited by 49
The Immediate Early Gene Product EGR1 and Polycomb Group Proteins Interact in Epigenetic Programming during Chondrogenesis
Spaapen, F., van den Akker, G., Caron, M. M. J., Prickaerts, P., Rofel, C., Dahlmans, V. E. H., Surtel, D. A., Paulis, Y. W. J., Schweizer, F., Welting, T. J. M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058083 · Cited by 50
HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3
Nagel, S., Scherr, M., Quentmeier, H., Kaufmann, M., Zaborski, M., Drexler, H. G., & MacLeod, R. A. F. (2005) · Leukemia · doi:10.1038/sj.leu.2403716 · Cited by 49
Role of stemness-related molecules in neuroblastoma
Kamijo, T. (2012) · Pediatric Research · doi:10.1038/pr.2011.54 · Cited by 49
Epigenetic Modifications in Prostate Cancer
Ngollo, M., Dagdemir, A., Karslı-Çeppioğlu, S., Judes, G., Pajon, A., Penault-Llorca, F. M., Boiteux, J., Bignon, Y., Guy, L., & Bernard-Gallon, D. J. (2014) · Epigenomics · doi:10.2217/epi.14.34 · Cited by 48
EZH2 overexpression in different immunophenotypes of breast carcinoma and association with clinicopathologic features
Guo, S., Li, X., Rohr, J. M., Wang, Y., Ma, S., Chen, P., & Wang, Z. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0491-5 · Cited by 48
Precision medicine driven by cancer systems biology
Filipp, F. V. (2017) · Cancer and Metastasis Reviews · doi:10.1007/s10555-017-9662-4 · Cited by 52
Identification of cellular targets for the human papillomavirus E6 and E7 oncogenes by RNA interference and transcriptome analyses
Kuner, R., Vogt, M., Sültmann, H., Buneß, A., Dymalla, S., Bulkescher, J., Fellmann, M., Butz, K., Poustka, A., & Hoppe‐Seyler, F. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0230-1 · Cited by 46
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
Baker, S. C., Mason, A. S., Slip, R. G., Skinner, K. T., Macdonald, A., Masood, O., Harris, R. S., Fenton, T. R., Periyasamy, M., Ali, S., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02235-8 · Cited by 45
Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.
Yang, C., LaBaff, A. M., Wei, Y., Nie, L., Xia, W., Huo, L., Yamaguchi, H., Hsu, Y. H., Hsu, J. L., Liu, D., et al. (2015) · PubMed Central · Cited by 47
The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids1
Yang, Q., Nair, S., Laknaur, A., Ismail, N., Diamond, M. P., & Al-Hendy, A. A. (2016) · Biology of Reproduction · doi:10.1095/biolreprod.115.134924 · Cited by 47
Loss of maternal EED results in postnatal overgrowth
Prokopuk, L., Stringer, J. M., White, C. R., Vossen, R. H. A. M., White, S. J., Cohen, A. S. A., Gibson, W. T., & Western, P. S. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0526-8 · Cited by 47
EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation
Mu, W., Starmer, J., Yee, D., & Magnuson, T. (2018) · Epigenetics & Chromatin · doi:10.1186/s13072-018-0242-9 · Cited by 52
The polycomb group protein EZH2 regulates actin polymerization in human prostate cancer cells
Bryant, R. J., Winder, S. J., Cross, S. S., Hamdy, F. C., & Cunliffe, V. T. (2007) · The Prostate · doi:10.1002/pros.20705 · Cited by 47
Circular RNAs in cell cycle regulation: Mechanisms to clinical significance
Xiao, W., Li, J., Hu, J., Wang, L., Huang, J. R., Sethi, G., & Ma, Z. (2021) · Cell Proliferation · doi:10.1111/cpr.13143 · Cited by 47
Biology of Polycomb and Trithorax Group Proteins
Breiling, A., Sessa, L., & Orlando, V. (2007) · International review of cytology · doi:10.1016/s0074-7696(07)58002-2 · Cited by 46
A key role for EZH2 in epigenetic silencing of HOX genes in mantle cell lymphoma
Kanduri, M., Sander, B., Ntoufa, S., Papakonstantinou, N., Sutton, L., Σταματόπουλος, Κ., Kanduri, C., & Rosenquist, R. (2013) · Epigenetics · doi:10.4161/epi.26546 · Cited by 46
Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes
Boulay, G., Rosnoblet, C., Guérardel, C., Angrand, P., & Leprince, D. (2011) · Biochemical Journal · doi:10.1042/bj20100944 · Cited by 46
Deregulated Expression of the Polycomb-Group Protein SUZ12 Target Genes Characterizes Mantle Cell Lymphoma
Martín-Pérez, D., Sánchez, E., Maestre, L., Suela, J., Vargiu, P., Lisio, L. D., Martı́nez, N., Alves, J., Piris, M. A., & Sánchez‐Beato, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090769 · Cited by 46
Targeting epigenetic machinery: Emerging novel allosteric inhibitors
Ye, F., Huang, J. L., Wang, H., Luo, C., & Zhao, K. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107406 · Cited by 47
Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3
Verlinden, L., Eelen, G., Beullens, I., Camp, M. V., Hummelen, P. V., Engelen, K., Hellemont, R. V., Marchal, K., Moor, B. D., Foijer, F., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503587200 · Cited by 45
KDM6B promotes activation of the oncogenic CDK4/6-pRB-E2F pathway by maintaining enhancer activity in MYCN-amplified neuroblastoma
D’Oto, A., Fang, J., Jin, H., Xu, B., Singh, S. V., Mullasseril, A., Jones, V. M., Abu‐Zaid, A., von Buttlar, X., Cooke, B., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27502-2 · Cited by 45
miR-101, downregulated in retinoblastoma, functions as a tumor suppressor in human retinoblastoma cells by targeting EZH2
Lei, Q., Shen, F., Wu, J., ZHANG, W., Wang, J., & Zhang, L. (2014) · Oncology Reports · doi:10.3892/or.2014.3167 · Cited by 45
Polycomb Repressor Complex 2 in Genomic Instability and Cancer
Veneti, Z., Gkouskou, K. K., & Eliopoulos, A. G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081657 · Cited by 49
Ezh2 inhibition in Kras-driven lung cancer amplifies inflammation and associated vulnerabilities
Serresi, M., Siteur, B., Hulsman, D., Schmitt, M. J., Lieftink, C., Morris, B., Cesaroni, M., Proost, N., Beijersbergen, R. L., van Lohuizen, M., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20180801 · Cited by 45
Epigenetic factor EPC1 is a master regulator of DNA damage response by interacting with E2F1 to silence death and activate metastasis-related gene signatures
Wang, Y., Alla, V., Goody, D., Gupta, S. K., Spitschak, A., Olaf Wolkenhauer, A., Pützer, B. M., & Engelmann, D. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv885 · Cited by 45
Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells
MacGrogan, D., Kalakonda, N., Álvarez, S., Scandura, J. M., Boccuni, P., Johansson, B., & Nimer, S. D. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20087 · Cited by 45
Mammalian Lysine Histone Demethylase KDM2A Regulates E2F1-Mediated Gene Transcription in Breast Cancer Cells
Rizwani, W., Schaal, C. M., Kunigal, S., Coppola, D., & Chellappan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100888 · Cited by 44
The Transcriptional Repressor ZBTB4 Regulates EZH2 Through a MicroRNA-ZBTB4-Specificity Protein Signaling Axis
Yang, W. S., Chadalapaka, G., Cho, S., Lee, S., Jin, U.-H., Jutooru, I., Choi, K., Leung, Y., Ho, S., Safe, S. H., et al. (2014) · Neoplasia · doi:10.1016/j.neo.2014.09.011 · Cited by 44
Regulation and role of post-translational modifications of enhancer of zeste homologue 2 in cancer development.
Lu, H., Li, G., Zhou, C., Jin, W., Qian, X., Wang, Z., Pan, H., Jin, H., & Wang, X. (2016) · PubMed Central · Cited by 45
A cytosolic Ezh1 isoform modulates a PRC2–Ezh1 epigenetic adaptive response in postmitotic cells
Bodega, B., Marasca, F., Ranzani, V., Cherubini, A., Valle, F. D., Neguembor, M. V., Wassef, M. A., Zippo, A., Lanzuolo, C., Pagani, M., et al. (2017) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3392 · Cited by 46
Effect of non-enzymatic glycosylation in the epigenetics of cancer
Rehman, S., Aatif, M., Rafi, Z., Khan, M. Y., Shahab, U., Ahmad, S., & Farhan, M. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.11.019 · Cited by 43
Mechanisms of Disease: biomarkers and molecular targets from microarray gene expression studies in prostate cancer
Cooper, C. S., Campbell, C., & Jhavar, S. G. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0946 · Cited by 46
Tipping the lysine methylation balance in disease
Black, J. C., & Whetstine, J. R. (2012) · Biopolymers · doi:10.1002/bip.22136 · Cited by 47
EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis
Mu, W., Starmer, J., Shibata, Y., Yee, D., & Magnuson, T. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.02.017 · Cited by 43
Resveratrol inhibits the proliferation of estrogen receptor-positive breast cancer cells by suppressing EZH2 through the modulation of ERK1/2 signaling
Hu, C., Liu, Y., Teng, M., Jiao, K., Zhen, J., Wu, M., & Li, Z. (2019) · Cell Biology and Toxicology · doi:10.1007/s10565-019-09471-x · Cited by 45
Exploiting epigenetic vulnerabilities in solid tumors: Novel therapeutic opportunities in the treatment of SWI/SNF-defective cancers
Chabanon, R. M., Morel, D., & Postel-Vinay, S. C. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.018 · Cited by 44
Regulation of Stem Cell Differentiation by Histone Methyltransferases and DemethylasesPreprint
Pasini, D., Bracken, A. P., Agger, K., Christensen, J. F., Hansen, K. H., Cloos, P. A., & Helin, K. (2008) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2008.73.009 · Cited by 45
Self-citation
Independent prognostic value of the basal‐like phenotype of breast cancer and associations with EGFR and candidate stem cell marker BMI‐1
Arnes, J. B., Collett, K., & Akslen, L. A. (2008) · Histopathology · doi:10.1111/j.1365-2559.2007.02957.x · Cited by 42
Polycomb repressor complex 2 regulates HOXA9 and HOXA10, activating ID2 in NK/T-cell lines
Nagel, S., Venturini, L., Márquez, V. E., Meyer, C., Kaufmann, M., Scherr, M., MacLeod, R. A. F., & Drexler, H. G. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-151 · Cited by 42
Carcinogenesis of Intraductal Papillary Mucinous Neoplasm of the Pancreas: Loss of MicroRNA-101 Promotes Overexpression of Histone Methyltransferase EZH2
Nakahara, O., Takamori, H., Iwatsuki, M., Baba, Y., Sakamoto, Y., Tanaka, H., Chikamoto, A., Horino, K., Beppu, T., Kanemitsu, K., et al. (2011) · Annals of Surgical Oncology · doi:10.1245/s10434-011-2068-6 · Cited by 43
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
Changchien, Y.-C., Tátrai, P., Papp, G., Sápi, J., Fónyad, L., Szendrői, M., Pápai, Z., & Sápi, Z. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-216 · Cited by 42
Expression of EZH2 is associated with poor outcome in colorectal cancer
Chen, Z., Yang, P., Li, W., He, F., Wei, J., Zhang, T., Zhong, J., Chen, H., & Cao, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.7647 · Cited by 42
Poly(ADP-ribose) Polymerase 1, PARP1, modifies EZH2 and inhibits EZH2 histone methyltransferase activity after DNA damage
Caruso, L. B., Martin, K. A., Lauretti, E., Hulse, M., Siciliano, M., Lupey-Green, L. N., Abraham, A., Skórski, T., & Tempera, I. (2018) · Oncotarget · doi:10.18632/oncotarget.24291 · Cited by 42
The TGFB2-AS1 lncRNA Regulates TGF-β Signaling by Modulating Corepressor Activity
Papoutsoglou, P., Tsubakihara, Y., Caja, L., Morén, A., Pallis, P., Ameur, A., Heldin, C., & Moustakas, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.08.028 · Cited by 42
A Functional Link between Nuclear RNA Decay and Transcriptional Control Mediated by the Polycomb Repressive Complex 2
Garland, W., Comet, I. V., Wu, M., Radzisheuskaya, A., Rib, L., Vitting‐Seerup, K., Lloret-Llinares, M., Sandelin, A., Helin, K., & Jensen, T. H. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.011 · Cited by 41
Self-citation
Tumor Suppressive Effects of miR-124 and Its Function in Neuronal Development
Sanuki, R., & Yamamura, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115919 · Cited by 42
EZH2 and NF-κB: A context-dependent crosstalk and transcriptional regulation in cancer
Kaur, P., Verma, S., Kushwaha, P. P., & Gupta, S. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216143 · Cited by 42
High expression of Polycomb group protein EZH2 predicts poor survival in salivary gland adenoid cystic carcinoma
Vékony, H., Raaphorst, F. M., Otte, A. P., van Lohuizen, M., Leemans, C. R., van der Waal, I., & Bloemena, E. (2008) · Journal of Clinical Pathology · doi:10.1136/jcp.2007.054262 · Cited by 41
Integrative Analysis Reveals the Transcriptional Collaboration between EZH2 and E2F1 in the Regulation of Cancer-Related Gene Expression
Xu, H., Xu, K., He, H. H., Zang, C., Chen, C.-H., Chen, Y., Qin, Q., Wang, S., Wang, C., Hu, S. S., et al. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-15-0313 · Cited by 39
PHF19 mediated regulation of proliferation and invasiveness in prostate cancer cells
Jain, P., Ballaré, C., Blanco, E., Vizán, P., & Croce, L. D. (2020) · eLife · doi:10.7554/elife.51373 · Cited by 41
The polycomb group proteins, BMI-1 and EZH2, are tumour-associated antigens
Steele, J. C., Torr, E., Noakes, K. L., Kalk, E., Moss, P. A. H., Reynolds, G. M., Hübscher, S. G., van Lohuizen, M., Adams, D., & Young, L. S. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603369 · Cited by 41
Expression of EZH2 in renal cell carcinoma as a novel prognostic marker
Lee, H. W., & Choe, M. (2012) · Pathology International · doi:10.1111/pin.12001 · Cited by 39
Genetic Polymorphisms in the Polycomb Group Gene EZH2 and the Risk of Lung Cancer
Yoon, K., Gil, H.-J., Han, J., Park, J., & Lee, J. S. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181c422d9 · Cited by 40
Collaboration of Kras and Androgen Receptor Signaling Stimulates EZH2 Expression and Tumor-Propagating Cells in Prostate Cancer
Cai, H., Memarzadeh, S., Stoyanova, T. I., Beharry, Z. M., Kraft, A. S., & Witte, O. N. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0228 · Cited by 40
Ago-RIP-Seq identifies Polycomb repressive complex I member CBX7 as a major target of miR-375 in prostate cancer progression
Pickl, J. M. A., Tichy, D., Kuryshev, V., Tolstov, Y. L., Falkenstein, M., Schüler, J. B., Reidenbach, D., Hotz‐Wagenblatt, A., Kristiansen, G., Roth, W., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10729 · Cited by 40
Expression signatures of HOX cluster genes in cervical cancer pathogenesis: Impact of human papillomavirus type 16 oncoprotein E7
Saha, S. S., Chowdhury, R. R., Mondal, N. R., Roy, S. S., & Sengupta, S. (2017) · Oncotarget · doi:10.18632/oncotarget.16619 · Cited by 40
A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro
Parfett, C. L. J., & Desaulniers, D. M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061179 · Cited by 41
The Role of Polycomb Group Protein BMI1 in DNA Repair and Genomic Stability
Fitieh, A. M., Locke, A. J., Motamedi, M., & Ismail, I. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062976 · Cited by 43
The molecular mechanisms and therapeutic potential of EZH2 in breast cancer
Adibfar, S., Elveny, M., Kashikova, H. S., Mikhailova, M. V., Farhangnia, P., Vakili‐Samiani, S., Tarokhian, H., & Jadidi‐Niaragh, F. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.120047 · Cited by 41
A chromatin-independent role of Polycomb-like 1 to stabilize p53 and promote cellular quiescencePreprint
Brien, G. L., Healy, E., Jerman, E., Conway, E., Fadda, E., O’Donovan, D., Krivtsov, A. V., Rice, A. M., Kearney, C. J., Flaus, A., et al. (2015) · Genes & Development · doi:10.1101/gad.267930.115 · Cited by 42
Self-citation
Bioinformatics analysis of thousands of TCGA tumors to determine the involvement of epigenetic regulators in human cancer
Gnad, F., Doll, S., Manning, G., Arnott, D. P., & Zhang, Z. (2015) · BMC Genomics · doi:10.1186/1471-2164-16-s8-s5 · Cited by 38
Polycomb Protein EED is Required for Silencing of Pluripotency Genes upon ESC Differentiation
Obier, N., Lin, Q., Cauchy, P., Hornich, V., Zenke, M., Becker, M., & Müller, A. M. (2014) · Stem Cell Reviews and Reports · doi:10.1007/s12015-014-9550-z · Cited by 39
A new metabolic gene signature in prostate cancer regulated by JMJD3 and EZH2
Daures, M., Idrissou, M., Judes, G., Rifai, K. T., Penault-Llorca, F. M., Bignon, Y., Guy, L., & Bernard-Gallon, D. J. (2018) · Oncotarget · doi:10.18632/oncotarget.25182 · Cited by 39
AP-2α–Mediated Activation of E2F and EZH2 Drives Melanoma Metastasis
White, J. R., Thompson, D. T., Koch, K. E., Kiriazov, B. S., Beck, A. C., van der Heide, D. M., Grimm, B. G., Kulak, M. V., & Weigel, R. J. (2021) · Cancer Research · doi:10.1158/0008-5472.can-21-0772 · Cited by 42
Targeting Enhancer of Zeste Homolog 2 as a promising strategy for cancer treatment
Marchesi, I., & Bagella, L. (2016) · World Journal of Clinical Oncology · doi:10.5306/wjco.v7.i2.135 · Cited by 38
Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies
Salvati, A., Melone, V., Giordano, A., Lamberti, J., Palumbo, D., Palo, L., Rea, D., Memoli, D., Simonis, V., Alexandrova, E., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06856-x · Cited by 40
EZH2 and ALDH1 expression in ductal carcinoma in situ: Complex association with recurrence and progression to invasive breast cancer
Knudsen, E. S., & Witkiewicz, A. (2013) · Cell Cycle · doi:10.4161/cc.25065 · Cited by 36
c-Rel Regulates Ezh2 Expression in Activated Lymphocytes and Malignant Lymphoid Cells
Neo, W. H., Lim, J. F., Grumont, R. J., Gerondakis, S., & Su, I.-H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.574517 · Cited by 42
EZH2 promotes a bi-lineage identity in basal-like breast cancer cells
Granit, R. Z., Gabai, Y., Hadar, T., Karamansha, Y., Liberman, L., Waldhorn, I., Gat‐Viks, I., Regev, A., Maly, B., Darash‐Yahana, M., et al. (2012) · Oncogene · doi:10.1038/onc.2012.390 · Cited by 38
Potential application of cell reprogramming techniques for cancer research
Saito, S., Lin, Y., Nakamura, Y., Eckner, R., Wuputra, K., Kuo, K., Lin, C., & Yokoyama, K. K. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2924-7 · Cited by 38
An oncogenic gene, SNRPA1, regulates PIK3R1, VEGFC, MKI67, CDK1 and other genes in colorectal cancer
Zeng, Q., Lei, F., Chang, Y., Gao, Z., Wang, Y., Gao, Q., Niu, P., & Li, Q. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109076 · Cited by 37
Exploiting the tumor-suppressive activity of the androgen receptor by CDK4/6 inhibition in castration-resistant prostate cancer
Han, W., Liu, M., Han, D. G., Toure, A. A., Li, M., Besschetnova, A., Wang, Z., Patalano, S. C., Macoska, J. A., Lam, H., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.039 · Cited by 36
Global Transcriptome Analysis Reveals That Poly(ADP-Ribose) Polymerase 1 Regulates Gene Expression through EZH2
Martin, K. A., Cesaroni, M., Denny, M. F., Lupey-Green, L. N., & Tempera, I. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.00635-15 · Cited by 37
Expression of the polycomb group protein EZH2 and its relation to outcome in patients with urothelial carcinoma of the bladder
Hinz, S., Kempkensteffen, C., Christoph, F., Hoffmann, M. J., Krause, H., Schrader, M. G., Schostak, M., Miller, K., & Weikert, S. (2007) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-007-0288-8 · Cited by 34

Authors: Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K.
Affiliations: European Institute of Oncology (IT)
IFOM (IT)
Corresponding author: Helin, Kristian
ORCID: Bracken, Adrian P.
Pasini, Diego
Helin, Kristian
Venue: The EMBO Journal
Publisher: Springer Science and Business Media LLC
Published: 2003-10-15
Volume: 22
Issue: 20
Pages: 5323-5335
ISSN: 0261-4189 (ISSN-L)
1460-2075
DOI: 10.1093/emboj/cdg542
PMC: PMC213796
OpenAlex: W2171439874
Cited by: 1,196
References: 43
Citations by year: 2026: 16 · 2025: 33 · 2024: 39 · 2023: 52 · 2022: 35 · 2021: 64 · 2020: 66 · 2019: 56 · 2018: 53 · 2017: 65 · 2016: 74 · 2015: 63 · 2014: 65 · 2013: 61 · 2012: 58
FWCI: 11.03
Type: journal article
Language: en
Update notices: correction (2024-02-12)
Open access: green
europepmc.org
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: The EMBO Journal (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
RePEc: Research Papers in Economics (submittedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
Funders: European Commission
Associazione Italiana per la Ricerca sul Cancro
Fondazione Italiana per la Ricerca sul Cancro
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Keywords: EZH2, Polycomb group genes, polycomb repressive complex 2, EED, oncogenes, cell proliferation, gene amplification, prostate cancer, lymphoma, histone methyltransferase, tumor formation
MeSH terms: Enhancer of Zeste Homolog 2 Protein, Animals, Base Sequence, Cell Division, Cell Line, DNA-Binding Proteins, Gene Amplification, Genetic Markers, Humans, Kinetics, Lymphoma, Male, Oncogenes, Promoter Regions, Genetic, Prostatic Neoplasms, Proteins, Recombinant Proteins, Transcription Factors, Transfection, Transcriptional Activation, Retinoblastoma Protein, DNA Primers, Cell Cycle Proteins, E2F Transcription Factors, Rats, Polycomb Repressive Complex 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks